Complete financial analysis of SITE Centers Corp. (SITC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SITE Centers Corp., a leading company in the REIT – Retail industry within the Real Estate sector.
You may be interested
- Brookmount Explorations Inc. (BMXI) Income Statement Analysis – Financial Results
- Acmos Inc. (6888.T) Income Statement Analysis – Financial Results
- Idogen AB (publ) (IDOGEN.ST) Income Statement Analysis – Financial Results
- Aris Water Solutions, Inc. (ARIS) Income Statement Analysis – Financial Results
- Shinsei Bank, Limited (8303.T) Income Statement Analysis – Financial Results
SITE Centers Corp. (SITC)
About SITE Centers Corp.
SITE Centers is an owner and manager of open-air shopping centers that provide a highly-compelling shopping experience and merchandise mix for retail partners and consumers. The Company is a self-administered and self-managed REIT operating as a fully integrated real estate company, and is publicly traded on the New York Stock Exchange under the ticker symbol SITC.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 546.28M | 540.81M | 492.34M | 416.76M | 447.75M | 654.86M | 879.45M | 969.51M | 995.10M | 953.77M | 888.79M | 800.38M | 771.02M | 803.07M | 819.31M | 931.47M | 944.85M | 818.10M | 727.18M | 598.93M | 476.10M | 357.24M | 322.24M | 285.79M | 263.93M | 228.17M | 169.04M | 130.91M | 108.60M | 81.80M | 51.70M |
| Cost of Revenue | 165.72M | 169.98M | 152.79M | 138.40M | 139.66M | 207.99M | 250.92M | 277.08M | 293.69M | 281.11M | 255.35M | 233.08M | 235.80M | 246.16M | 254.47M | 257.12M | 133.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 380.55M | 370.82M | 339.56M | 278.36M | 308.09M | 446.87M | 628.53M | 692.42M | 701.41M | 672.66M | 633.44M | 567.30M | 535.22M | 556.91M | 564.84M | 674.35M | 811.52M | 818.10M | 727.18M | 598.93M | 476.10M | 357.24M | 322.24M | 285.79M | 263.93M | 228.17M | 169.04M | 130.91M | 108.60M | 81.80M | 51.70M |
| Gross Profit Ratio | 69.66% | 68.57% | 68.97% | 66.79% | 68.81% | 68.24% | 71.47% | 71.42% | 70.49% | 70.53% | 71.27% | 70.88% | 69.42% | 69.35% | 68.94% | 72.40% | 85.89% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 50.87M | 46.56M | 55.05M | 52.88M | 58.38M | 61.64M | 89.85M | 76.10M | 73.38M | 84.48M | 79.56M | 76.44M | 85.22M | 85.57M | 94.37M | 97.72M | 81.24M | 60.68M | 54.05M | 47.13M | 40.82M | 29.39M | 24.38M | 20.45M | 17.77M | 12.92M | 11.06M | 8.44M | 6.40M | 5.60M | 4.10M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -15.36M | -15.84M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 50.87M | 46.56M | 55.05M | 52.88M | 58.38M | 61.64M | 89.85M | 76.10M | 73.38M | 84.48M | 79.56M | 76.44M | 85.22M | 85.57M | 79.00M | 81.88M | 81.24M | 60.68M | 54.05M | 47.13M | 40.82M | 29.39M | 24.38M | 20.45M | 17.77M | 12.92M | 11.06M | 8.44M | 6.40M | 5.60M | 4.10M |
| Other Expenses | 0.00 | 203.55M | 185.77M | 170.67M | 165.09M | 242.10M | -95.36M | 39.62M | 31.23M | 19.65M | -6.63M | -17.88M | 222.66M | 222.86M | 227.19M | 242.03M | 328.08M | 401.31M | 349.01M | 281.19M | 436.63M | 326.34M | 302.62M | 114.62M | 104.34M | 204.15M | 139.39M | 111.53M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 45.87M | 250.11M | 240.82M | 223.55M | 223.47M | 303.74M | 446.85M | 465.62M | 475.43M | 487.31M | 397.63M | 325.23M | 307.88M | 308.44M | 321.55M | 596.87M | 409.32M | 461.99M | 403.06M | 328.32M | 477.45M | 355.73M | 326.99M | 135.07M | 122.11M | 217.07M | 150.45M | 119.96M | -43.60M | -33.40M | -23.10M |
| Cost & Expenses | 430.47M | 420.09M | 393.61M | 361.95M | 363.13M | 511.73M | 697.77M | 742.70M | 769.12M | 768.42M | 652.99M | 558.30M | 543.67M | 554.60M | 576.02M | 596.87M | 542.66M | 461.99M | 403.06M | 328.32M | 477.45M | 355.73M | 326.99M | 135.07M | 122.11M | 217.07M | 150.45M | 119.96M | -43.60M | -33.40M | -23.10M |
| Interest Income | 0.00 | 0.00 | 0.00 | 11.89M | 18.01M | 20.44M | 28.36M | 37.05M | 29.21M | 15.93M | 23.54M | 15.80M | 9.83M | 7.35M | 12.11M | 5.47M | 8.81M | 0.00 | 0.00 | 0.00 | 5.08M | 5.91M | 6.42M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 82.00M | 77.69M | 77.03M | 77.60M | 84.72M | 141.31M | 188.65M | 217.59M | 241.73M | 237.12M | 228.87M | 221.42M | 229.72M | 226.46M | 237.94M | 244.21M | 258.15M | 0.00 | 0.00 | 0.00 | 240.26M | 101.97M | 92.37M | 100.83M | 87.40M | 77.92M | 67.52M | 49.54M | 25.50M | 21.20M | 8.60M |
| Depreciation & Amortization | 212.46M | 203.55M | 185.77M | 170.67M | 165.09M | 242.10M | 346.20M | 389.52M | 402.05M | 402.83M | 318.08M | 248.78M | 222.66M | 222.86M | 227.19M | 242.03M | 224.38M | 193.53M | 170.70M | 132.65M | 95.22M | 78.37M | 64.49M | 54.20M | 52.44M | 43.18M | 32.31M | 25.06M | 23.60M | 17.40M | 10.90M |
| EBITDA | 339.27M | 361.16M | 372.32M | 263.06M | 323.04M | 338.23M | 577.39M | 667.87M | 656.21M | 634.70M | 514.62M | 456.09M | 230.11M | 252.22M | 244.64M | 337.90M | 629.59M | 549.64M | 494.82M | 403.26M | 417.48M | 222.98M | 64.49M | 196.19M | 415.86M | 359.46M | 285.80M | 218.10M | 175.80M | 132.60M | 85.70M |
| EBITDA Ratio | 62.11% | 66.78% | 75.62% | 63.12% | 72.15% | 51.65% | 53.41% | 73.10% | 68.87% | 66.55% | 64.99% | 65.47% | 61.42% | 60.30% | 60.63% | 52.91% | 66.63% | 67.24% | 68.39% | 67.63% | 19.72% | 22.36% | 18.54% | 71.70% | 73.60% | 23.68% | 28.03% | 27.51% | 161.60% | 162.10% | 165.76% |
| Operating Income | 339.27M | 157.61M | 186.55M | 92.39M | 157.95M | 96.12M | 637.03M | 692.42M | 701.41M | 672.66M | 221.41M | 196.76M | 214.91M | 65.10M | -119.34M | 169.00M | 261.41M | 250.78M | 282.99M | 271.23M | 240.26M | 101.97M | 92.37M | 100.83M | 87.40M | 77.92M | 67.52M | 49.54M | 25.50M | 21.20M | 8.60M |
| Operating Income Ratio | 62.11% | 29.14% | 37.89% | 22.17% | 35.28% | 14.68% | 72.44% | 71.42% | 70.49% | 70.53% | 24.91% | 24.58% | 27.87% | 8.11% | -14.57% | 18.14% | 27.67% | 30.65% | 38.92% | 45.29% | 50.46% | 28.54% | 28.67% | 35.28% | 33.11% | 34.15% | 39.94% | 37.85% | 23.48% | 25.92% | 16.63% |
| Total Other Income/Expenses | -71.50M | -188.46M | -12.29M | -62.36M | -41.49M | -76.27M | -456.83M | -273.51M | -490.55M | -194.30M | -510.01M | -113.39M | -250.28M | -211.28M | -198.46M | -279.60M | -71.96M | -182.52M | -139.86M | -86.31M | 73.04M | -38.81M | -74.95M | -67.88M | 0.00 | -314.76M | -252.10M | 0.00 | -152.20M | 0.00 | 0.00 |
| Income Before Tax | 267.77M | 169.61M | 126.97M | 37.72M | 102.48M | -108.44M | -402.67M | -10.41M | -231.60M | 22.96M | 4.60M | -13.62M | -41.54M | -146.18M | -317.80M | -89.94M | 189.90M | 173.59M | 184.26M | 184.31M | 240.26M | 101.97M | 92.37M | 100.83M | 87.40M | 77.92M | 67.52M | 49.54M | 25.50M | 21.20M | 8.60M |
| Income Before Tax Ratio | 49.02% | 31.36% | 25.79% | 9.05% | 22.89% | -16.56% | -45.79% | -1.07% | -23.27% | 2.41% | 0.52% | -1.70% | -5.39% | -18.20% | -38.79% | -9.66% | 20.10% | 21.22% | 25.34% | 30.77% | 50.46% | 28.54% | 28.67% | 35.28% | 33.11% | 34.15% | 39.94% | 37.85% | 23.48% | 25.92% | 16.63% |
| Income Tax Expense | 2.05M | 816.00K | 1.55M | 1.13M | 659.00K | 862.00K | 1.62M | 1.78M | 6.29M | 1.86M | 2.71M | 1.16M | 1.04M | 47.99M | -691.00K | -17.43M | -14.64M | -2.48M | 342.00K | 1.47M | -240.26M | -101.97M | -92.37M | -100.83M | -87.40M | -77.92M | -67.52M | -49.54M | -25.50M | -21.20M | -8.60M |
| Net Income | 265.70M | 168.72M | 124.94M | 35.72M | 100.70M | -109.30M | -241.69M | 60.01M | -72.17M | 117.28M | -10.18M | -25.82M | -15.85M | -209.36M | -356.59M | -57.78M | 276.05M | 253.26M | 282.64M | 269.76M | 240.26M | 101.97M | 92.37M | 100.83M | 87.40M | 77.92M | 67.52M | 49.54M | 25.50M | 21.20M | 8.60M |
| Net Income Ratio | 48.64% | 31.20% | 25.38% | 8.57% | 22.49% | -16.69% | -27.48% | 6.19% | -7.25% | 12.30% | -1.14% | -3.23% | -2.06% | -26.07% | -43.52% | -6.20% | 29.22% | 30.96% | 38.87% | 45.04% | 50.46% | 28.54% | 28.67% | 35.28% | 33.11% | 34.15% | 39.94% | 37.85% | 23.48% | 25.92% | 16.63% |
| EPS | 4.85 | 2.96 | 2.04 | 0.74 | 2.20 | -2.37 | -5.26 | 1.31 | -1.60 | 2.00 | -0.25 | -0.72 | -0.47 | -6.84 | -17.96 | -3.48 | 13.41 | 13.12 | 15.14 | 16.37 | 16.66 | 11.55 | 12.07 | 12.95 | 10.27 | 9.89 | 7.43 | 6.06 | 4.61 | 4.83 | 2.74 |
| EPS Diluted | 4.85 | 2.92 | 2.04 | 0.74 | 2.20 | -2.37 | -5.26 | 1.31 | -1.60 | 2.00 | -0.25 | -0.72 | -0.47 | -6.84 | -17.96 | -3.47 | 13.34 | 13.05 | 15.00 | 16.15 | 16.37 | 11.34 | 11.97 | 12.95 | 9.96 | 9.50 | 7.43 | 5.99 | 4.61 | 4.76 | 2.74 |
| Weighted Avg Shares Out | 52.36M | 53.25M | 52.00M | 48.33M | 45.76M | 46.13M | 45.92M | 45.66M | 45.11M | 44.76M | 40.80M | 35.88M | 33.78M | 30.59M | 19.85M | 16.62M | 16.76M | 15.09M | 15.02M | 13.38M | 11.35M | 8.83M | 7.65M | 7.79M | 8.51M | 7.88M | 7.18M | 7.66M | 5.53M | 4.39M | 3.14M |
| Weighted Avg Shares Out (Dil) | 52.41M | 53.47M | 52.29M | 48.44M | 45.81M | 46.13M | 45.92M | 45.70M | 45.11M | 44.76M | 40.80M | 35.88M | 33.93M | 30.59M | 19.85M | 16.64M | 16.85M | 15.18M | 15.17M | 13.56M | 11.55M | 8.99M | 7.72M | 7.79M | 8.78M | 8.20M | 7.18M | 7.66M | 5.53M | 4.45M | 3.14M |
IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting
NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based on its T-win® platform, today announced two abstracts accepted for poster presentation at the Society for...
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting
BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today announced it will deliver an oral and a poster...
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting
WATERTOWN, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer,...
Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors or hematologic malignancies, announced today that three abstracts...
AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024.
Curbline Properties Announces Tax Basis
NEW YORK--(BUSINESS WIRE)--On October 1, 2024, Curbline Properties Corp. (NYSE: CURB) (“CURB” or “Curbline”) completed its separation from SITE Centers Corp. (NYSE: SITC) (“SITC”) and became an independent publicly traded company. In the separation, SITC distributed two CURB common shares...
SITC Closes Curbline Spin-Off, Disposes Properties Worth $610.1M
SITE Centers announces completion of Curbline spinoff. It also provides an update on its transaction activity from Sept.
SITE Centers: Curbline Properties IPO Prices In Line With Valuations
SITE Centers Corp. is a retail REIT focused on retail locations close to residents with a high household income. The company successfully spun off its premium assets in a new REIT called Curbline Properties, achieving a 6% cap rate. Curbline...
SITE Centers Announces Completion of Spin-Off of Curbline Properties
BEACHWOOD, Ohio--(BUSINESS WIRE)--SITE Centers Corp. (NYSE: SITC) (the “Company” or “SITE Centers”) today announced that it has completed the previously announced spin-off of Curbline Properties Corp. (“Curbline”), which is now an independent, publicly traded company that will begin regular-way trading...
SITE Centers Provides Transaction and Curbline Balance Sheet Update
BEACHWOOD, Ohio--(BUSINESS WIRE)--SITE Centers Corp. (NYSE: SITC) (the “Company” or “SITE Centers”), an owner of open-air shopping centers in suburban, high household income communities, today provided an update on transaction activity along with updated projected Curbline Properties Corp. (“Curbline”) balance...
Source: https://incomestatements.info
Category: Stock Reports